| Literature DB >> 30621064 |
Keum Hwa Lee1,2, Ji Sun Hong3, Hyuk Jun Jung4, Hyun Ki Jeong5, Seo Jin Moon6, Woo Hyun Park7, Yoon Mi Jeong8, Seung Won Song9, Yongjune Suk10, Min Ji Son11, Jae Jung Lim12, Jae Il Shin13,14,15.
Abstract
Imperforate hymen (IH) is an uncommon congenital anomaly of the female genital tract, with the hymen completely obstructing the vaginal opening. Despite the simple diagnosis and treatment of IH, missed or delayed diagnosis is often a clinical problem owing to its low incidence, nonspecific symptoms, or insufficient physical examination. The aim of this study is to identify the characteristics, clinical presentations, treatment modalities, and outcomes of imperforate hymen patients. In this study, a literature search of PubMed, Scopus and Medline databases was performed for sources published up to 3 July 2018 for English-language studies with the term "imperforate hymen". The literature review identified 251 citations and 155 articles (143 case reports, 12 case series) containing 253 patients who were finally included (two papers were not written in English). Among 236 postnatal patients, the mean age of the patients was 10.7 ± 4.7 years. Abdominal pain (54.2%), urinary retention (20.3%), abnormal menstruation (14.0%), dysuria (9.7%), increased urinary frequency (5.1%), severe presentation of renal failure (n = 5, 2.1%), and urinary tract infection (n = 1, 0.4%) were presented. Most patients diagnosed with the condition underwent surgical treatment (83.5%), most of whom were treated via a hymenotomy (35.2%) and hymenectomy (36.4%), and the use of prophylactic antibiotics were only used in 7 patients. There were no differences in outcomes between two surgical methods. In addition, 141 (59.7%) patients showed improvement and 5 deceased patients were not related to IH or the operation itself; Complications, such as vaginal adhesion, were only noted in 6.6% of patients. In addition, among 17 cases of newborns with a diagnosis of IH before birth, hymenectomy (n = 5, 29.4%) and hymenotomy (n = 9, 52.9%) were the main treatment modalities and showed improved prognosis in 52.9% of newborns. Because IH diagnosis is easy and postsurgical prognosis is good, clinicians should carefully examine every female patient at birth. IH should be considered regarding adolescent girls with abdominal pain, lower back pain, or urinary retention, and perform appropriate physical examinations of the genital introitus. In addition, accurate diagnosis as IH, not misdiagnosing as vaginal septum or agenesis, is important to prevent severe complications such as stricture and ascending infection.Entities:
Keywords: abdominal pain; genitourinary symptoms; hymenectomy; hymenotomy; imperforate hymen; improvement; systematic review
Year: 2019 PMID: 30621064 PMCID: PMC6352236 DOI: 10.3390/jcm8010056
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241
Figure 1Flow chart of literature search.
Characteristics of case-reported patients with imperforate hymen.
| Variables | Total Number of Patients ( |
|---|---|
| Number of Patients (%) | |
| Neonate (<1 month) | 26 (11.0%) |
| Infant (1 month–2 years) | 13 (5.5%) |
| Child (2 years–12 years) | 33 (14.0%) |
| Adolescent (12 years–18 years) | 153 (64.8%) |
| Adult (>18 years) | 11 (4.7%) |
| Female | 236 (100%) |
| Male | 0 (0.0%) |
| Asia | 37 (15.7%) |
| Europe | 52 (22.0%) |
| Africa | 13 (5.5%) |
| America | 105 (44.5%) |
| Middle east | 29 (12.3%) |
| One | 94 (40.0%) |
| More than one * | 45 (19.1%) |
| Familial history of imperforate hymen | 22 (9.3%) |
| Menstruation | 8 (3.4%) |
| Hymenotomy or hymenectomy | 6 (2.5%) |
| Abuse | 5 (2.1%) |
| Central precocious puberty | 2 (0.8%) |
| Previously hymen opened | 1 (0.4%) |
| Labial adhesion | 1 (0.4%) |
| Misdiagnosed as Müllerian agenesis treated with vaginal dilator | 1 (0.4%) |
| Yes | 48 (20.3%) |
| No | 188 (79.7%) |
* More than one doctor refers to 2 (n = 34), 3 (n = 8), 4 (n = 1), 6 (n = 1), or more than 7 doctors (n = 1). † Multiple abnormalities include absent left radius, angiomyolipoma arises primarily in the kidneys, anorectal atresia, bicornuate uterus, bilateral duplex ureter, bilateral hydronephrosis, cloaca, congenital heart defects, didelphic uterus with or without double vagina, double genital system, duplex kidney, Escobar syndrome, hematocolpometra, high aortic bifurcation, imperforate anus, ipsilateral renal agenesis, labial adhesion, Langer–Giedion syndrome, left hypoplastic kidney with ectopic ureter, McKusick–Kaufman syndrome (MKKS), mild subluxation of the hips, persistent cloaca, primary vaginal calculus, right absent ureter, right cystic dysplastic kidney, rupture of bladder, sacral agenesis, systemic aplasia cutis congenital, transverse vaginal septum, ulnar mammary syndrome, unicornuate uterus, urethrovaginal fistula, vaginal atresia, and vaginal occlusion by an imperforate hymen.
Clinical presentation of case-reported patients with imperforate hymen.
| Clinical Presentation | Total Number of Patients ( |
|---|---|
| Number of Patients (%) | |
| Fever | 5 (2.1%) |
| Hot flushes | 2 (0.8%) |
| Lethargy | 3 (1.3%) |
| Loss of appetite | 2 (0.8%) |
| General discomfort | 2 (0.8%) |
| Weight gain | 1 (0.4%) |
| Poor feeding | 1 (0.4%) |
| Sudden chest pain with swelling of the upper torso | 1 (0.4%) |
| Tachypnea | 1 (0.4%) |
| 23 (9.7%) | |
| Respiratory distress | 2 (0.8%) |
| Rapid breathing | 1 (0.4%) |
| Thoracoabdominal respiration | 1 (0.4%) |
| Abdominal pain | 128 (54.2%) |
| Abdominal discomfort | 10 (4.2%) |
| Abdominal distension | 18 (7.6%) |
| Constipation | 13 (5.5%) |
| Diarrhea | 3 (1.3%) |
| Vomiting | 5 (2.1%) |
| Nausea | 5 (2.1%) |
| Tenesmus | 2 (0.8%) |
| Fecal frequency and urgency | 1 (0.4%) |
| Inability to pass meconium | 1 (0.4%) |
| Peritoneal sign | 1 (0.4%) |
| Urinary retention | 48 (20.3%) |
| Urinary frequency | 12 (5.1%) |
| Urinary incontinence | 4 (1.7%) |
| Urinary urgency | 2 (0.8%) |
| Urinary hesitancy | 1 (0.4%) |
| Nocturia | 2 (0.8%) |
| Renal failure | 5 (2.1%) |
| Urinary tract infection | 1 (0.4%) |
| Bladder distension | 1 (0.4%) |
| Straining during urination | 1 (0.4%) |
| Polyuria | 1 (0.4%) |
| Oliguria | 1 (0.4%) |
| Dysuria | 23 (9.7%) |
| Abnormal menstruation * | 33 (14.0%) |
| Heavy vaginal bleeding | 1 (0.4%) |
| Others | 10 (4.2%) |
| Perineal pain and pruritus | 1 (0.4%) |
| Perineal bulge | 7 (3.0%) |
| Large interlabial swelling | 1 (0.4%) |
| Vaginal irritation/tenderness/fullness/swelling | 4 (1.6%) |
| Problems in sexual intercourse | 1 (0.4%) |
| Back pain | 21 (8.9%) |
| Leg pain | 2 (0.8%) |
| Lower limb swelling | 2 (0.8%) |
| Headache | 3 (1.2%) |
| Epileptic attacks | 1 (0.4%) |
| Syncope | 1 (0.4%) |
| Irritability | 1 (0.4%) |
| 15 (6.4%) |
* Abnormal menstruation refers to unknown abnormal menstruation (n = 1), scanty menstruation (n = 1), dysmenorrhea (n = 1), and amenorrhea (n = 30). † Others refer to primary infertility (n = 1), dyspareunia (n = 2), nonimmune hydrops fetalis (n = 1), anorectal atresia (n = 1), multiple anomalies (n = 3), appendicitis (n = 3), pelvic pressure (n = 1), suprapubic pain (n = 1), appearance of pubic hair and breast enlargement (n = 1), and breast tenderness (n = 1).
Treatment of case-reported patients with imperforate hymen.
| Treatment | Total Number of Patients ( |
|---|---|
| Number of Patients (%) | |
| Hymenotomy | 83 (35.2%) |
| Hymenectomy | 86 (36.4%) |
| Laparotomy | 5 (2.1%) |
| Vaginal septum repair | 4 (1.7%) |
| Vaginoplasty | 1 (0.4%) |
| Vaginal canal extraction | 1 (0.4%) |
| Vaginal septoplasty | 1 (0.4%) |
| Vaginal orifice dilatation | 3 (1.3%) |
| Perforation and dilatation of hymen | 1 (0.4%) |
| Puncture of hymen | 1 (0.4%) |
| Unknown surgical correction | 1 (0.4%) |
| Surgical incision of the imperforate hymen | 1 (0.4%) |
| Excision of fistula | 1 (0.4%) |
| Simple closure of fistula | 1 (0.4%) |
| Repairing urethrovaginal fistula | 1 (0.4%) |
| Removal of calculi in pelvis | 1 (0.4%) |
| Laparoscopic adhesiolysis | 2 (0.8%) |
| Bladder suturing | 1 (0.4%) |
| Anal cut back operation | 1 (0.4%) |
| Abdominoperineal pull-through | 1 (0.4%) |
| Prophylactic antibiotics | 7 (3.0%) |
| Irrigation of vaginal cavity with antibiotic solution | 1 (0.4%) |
| GnRH agonist | 1 (0.4%) |
* Except GnRH agonist, all the medical therapies were used in combination with surgical therapies. A GnRH agonist was used as a mono-therapeutic agent in an 18-month-old Asian patient [14]. The patient had a history of central precocious puberty and a combined abnormality of vaginal atresia. The patient’s chief complaint was the appearance of pubic hair and breast enlargement.
Outcomes of case-reported patients with imperforate hymen.
| Outcome | Total Number of Patients ( |
|---|---|
| Number of Patients (%) | |
| Improved | 141 (59.7%) |
| Complicated * | 15 (6.6%) |
| Died † | 5 (2.1%) |
| Unknown | 75 (31.8%) |
* Complication includes reclosure (n = 4), vaginal adenosis (n = 2), vaginal adhesion (n = 1), destruction of the urethral sphincter and bladder (n = 1), development of cicatricial stenosis in upper vagina (n = 1), vaginal canal adhesion (n = 1), amenorrhea (n = 1), second hymenotomy (n = 1), fusion of vaginal septum (n = 1), and unknown (n = 2). Strictly, amenorrhea (n = 1) is not a complication of the operation but we inserted this patient into the complicated cases because the patient showed no menstruation for 1 year after surgery in one article. † Cause of death was cardiorespiratory distress (n = 3), sepsis and acute kidney injury (n = 1), or asphyxia and dehydration (n = 1).
Outcomes of case-reported patients with imperforate hymen.
| Variables | Total Number of Improved Patients ( | Total Number of Complicated * Patients ( | Total Number of Deceased † Patients ( |
|---|---|---|---|
| Number of Patients (%) | Number of Patients (%) | Number of Patients (%) | |
| Neonate, prenatal (<1 month) | 13 (9.2%) | 1 (6.7%) | 5 (100.0%) |
| Infant (1 month–2 years) | 5 (3.5%) | 1 (6.7%) | 0 (0.0%) |
| Child (2 years–12 years) | 13 (9.2%) | 2 (13.3%) | 0 (0.0%) |
| Adolescent (12 years–18 years) | 101 (71.6%) | 9 (60.0%) | 0 (0.0%) |
| Adult (>18 years) | 9 (6.4%) | 2 (13.3%) | 0 (0.0%) |
| Asia | 27 (19.1%) | 3 (20.0%) | 1 (20.0%) |
| Europe | 28 (19.9%) | 4 (26.7%) | 3 (60.0%) |
| Africa | 8 (5.7%) | 1 (6.7%) | 1 (20.0%) |
| America | 54 (38.3%) | 7 (46.7%) | 0 (0.0%) |
| Middle east | 24 (17.0%) | 0 (0.0%) | 0 (0.0%) |
| One | 67 (47.5%) | 9 (60.0%) | -(-%) |
| More than one | 37 (26.2%) | 3 (20.0%) | -(-%) |
| Familial history of imperforate hymen | 14 (9.9%) | 0 (0.0%) | 0 (0.0%) |
| Menstruation | 5 (3.5%) | 1 (6.7%) | 0 (0.0%) |
| Hymenotomy or hymenectomy | 5 (3.5%) | 0 (0.0%) | 0 (0.0%) |
| Abuse | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
| Central precocious puberty | 2 (1.4%) | 0 (0.0%) | 0 (0.0%) |
| Labial adhesion | 1 (0.7%) | 0 (0.0%) | 0 (0.0%) |
| Yes | 26 (18.4%) | 3 (20.0%) | 5 (100.0%) |
| Transverse vaginal septum | 4 (2.8%) | 1 (6.7%) | 0 (0.0%) |
| No | 116 (82.3%) | 12 (80.0%) | 0 (0.0%) |
| Amenorrhea | 21 (14.9%) | 4 (26.7%) | 0 (0.0%) |
| Abdominal pain | 86 (61.0%) | 11 (73.3%) | 0 (0.0%) |
| Abdominal discomfort | 5 (3.5%) | 1 (6.7%) | 0 (0.0%) |
| Back pain | 13 (9.2%) | 1 (6.7%) | 0 (0.0%) |
| Abdominal distension | 13 (9.2%) | 1 (6.7%) | 1 (20.0%) |
| Bladder distension | 3 (2.1%) | 0 (0.0%) | 0 (0.0%) |
| Urinary frequency | 10 (7.1%) | 0 (0.0%) | 0 (0.0%) |
| Urinary retention | 39 (27.7%) | 1 (6.7%) | 1 (20.0%) |
| Constipation | 4 (2.8%) | 1 (6.7%) | 0 (0.0%) |
| Headache | 2 (1.4%) | 1 (6.7%) | 0 (0.0%) |
| Dysuria | 11 (7.8%) | 3 (20.0%) | 0 (0.0%) |
| Renal failure | 5 (3.5%) | 0 (0.0%) | 0 (0.0%) |
| Urinary tract infection (UTI) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
| Palpable mass | 12 (8.5%) | 2 (13.3%) | 0 (0.0%) |
| Hymenectomy | 66 (46.8%) | 9 (60.0%) | 1 (20.0%) |
| Hymenotomy | 66 (46.8%) | 3 (20.0%) | 0 (0.0%) |
| Vaginoplasty | 1 (0.7%) | 0 (0.0%) | 0 (0.0%) |
| Vaginal septum repair | 4 (2.8%) | 2 (13.3%) | 0 (0.0%) |
| Vaginal orifice dilatation | 2 (1.4%) | 1 (6.7%) | 0 (0.0%) |
| Observation | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
| Prophylactic antibiotics | 5 (3.5%) | 1 (6.7%) | 0 (0.0%) |
| Laparotomy | 4 (2.8%) | 0 (0.0%) | 0 (0.0%) |
* Complication includes reclosure (n = 4), vaginal adenosis (n = 2), vaginal adhesion (n = 1), destruction of the urethral sphincter and bladder (n = 1), development of cicatricial stenosis in upper vagina (n = 1), vaginal canal adhesion (n = 1), amenorrhea (n = 1), second hymenotomy (n = 1), fusion of vaginal septum (n = 1), and unknown (n = 2). Strictly, amenorrhea (n = 1) is not a complication of the operation but we inserted this patient into the complicated cases because the patient showed no menstruation for 1 year after surgery in one article. † Causes: Cardiorespiratory distress (n = 3), Sepsis and acute kidney injury (n = 1) and Asphyxia and dehydration (n = 1). ‡ There is no explanation of the number of doctors in deceased patients. ** Combined abnormality contains bilateral hydronephrosis, transverse vaginal septum, bicornuate uterus, etc.
Demographics of case-reported newborns diagnosed with imperforate hymen before birth.
| Variables | Total Number of Patients ( |
|---|---|
| Number of Patients (%) | |
| <20 | 1 (5.9%) |
| 20–24 | 0 (0.0%) |
| 25–29 | 5 (29.4%) |
| 30–35 | 3 (17.6%) |
| >35 | 6 (35.3%) |
| Unknown | 2 (11.8%) |
| Primipara | 7 (41.2%) |
| Multipara | 7 (41.2%) |
| Unknown | 3 (17.6%) |
| Preterm (<38) | 13 (76.5%) |
| Normal (38–42) | 3 (17.6%) |
| Post-term (>42) | 0 (0.0%) |
| Unknown | 1 (5.9%) |
| Hydrocolpos | 1 (5.9%) |
| Hydrometrocolpos | 5 (29.4%) |
| Fetal pelvic cyst/mass | 2 (11.8%) |
| Hydronephrosis | 1 (5.9%) |
| Hydrocolpos + Fetal pelvic cyst/mass | 1 (5.9%) |
| Hydrometrocolpos + Fetal pelvic cyst/mass | 1 (5.9%) |
| Fetal pelvic cyst/mass + Hydronephrosis | 2 (11.8%) |
| Fetal pelvic cyst/mass + Kidney pelvic dilatation | 1 (5.9%) |
| Hydrocolpos + Fetal pelvic cyst/mass + Hydronephrosis | 2 (11.8%) |
| Hymenectomy | 5 (29.4%) |
| Hymenotomy | 9 (52.9%) |
| Others ‡ | 3 (17.6%) |
| Improved | 9 (52.9%) |
| Complicated | 1 (5.9%) |
| Died | 1 (5.9%) |
| Unknown | 6 (35.3%) |
* Hydrocolpos, hydrometrocolpos, fetal pelvic cyst/mass, and hydronephrosis. † Fetal ascites and distended uterus and vagina was diagnosed by ultrasonography finding. ‡ One patient self-limited, another patient did only observation, and the other patient did not know what treatment they underwent.